Lanlan Chen
Impact in
- Hepatology top 10%
- Reproductive Medicine top 10%
- Sperm and Testicular Function
Papers in
- Surgery 14
- Epidemiology 14
- Hepatitis B Virus Studies 7
- Liver Disease Diagnosis and Treatment 5
- Co-authors
- Guoyue Lv (11 shared papers)Chang He (4 shared papers)Yang Liu (1 shared paper)Haitao Li (1 shared paper)Ren‐Shan Ge (13 shared papers)Yan Chen (2 shared papers)Xue You (1 shared paper)Lin Wang (1 shared paper)
- Journals
- Frontiers in Pharmacology (4 papers)Pharmacology (2 papers)Hepatology International (2 papers)Scientific Reports (2 papers)Therapeutics and Clinical Risk Management (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Lanlan Chen
123 papers receiving 1.8k citations
Lanlan Chen's Hit Papers
Peers
Comparison fields: 5 of 139
- Hepatology 88
- Reproductive Medicine 73
- Cognitive Neuroscience 154
- Cancer Research 98
- Physiology 165
Countries citing papers authored by Lanlan Chen
This map shows the geographic impact of Lanlan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Chen more than expected).
Fields of papers citing papers by Lanlan Chen
This network shows the impact of papers produced by Lanlan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Chen. The network helps show where Lanlan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lanlan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 132 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Insights into modifiable risk factors of cholelithiasis: A Mendelian randomization study Hit paper breakdown → | 2021 | 162 |
| 2 | 2018 | 141 | |
| 3 | 2014 | 119 | |
| 4 | 2016 | 72 | |
| 5 | 2016 | 56 | |
| 6 | 2015 | 49 | |
| 7 | 2015 | 44 | |
| 8 | 2014 | 44 | |
| 9 | 2021 | 40 | |
| 10 | 2022 | 39 | |
| 11 | 2017 | 38 | |
| 12 | 2017 | 34 | |
| 13 | 2023 | 32 | |
| 14 | 2017 | 32 | |
| 15 | 2024 | 31 | |
| 16 | 2018 | 29 | |
| 17 | 2020 | 27 | |
| 18 | 2020 | 26 | |
| 19 | 2015 | 26 | |
| 20 | 2022 | 23 |
About Lanlan Chen
Lanlan Chen is a scholar working on Surgery, Epidemiology, Genetics, Molecular Biology and Endocrinology, Diabetes and Metabolism, having authored 132 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (7 papers), Genetic Associations and Epidemiology (7 papers), Sperm and Testicular Function (6 papers), Adipose Tissue and Metabolism (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Parkinson's Disease Mechanisms and Treatments (5 papers), Liver Diseases and Immunity (4 papers) and Hormonal Regulation and Hypertension (4 papers). The work is most often cited by research in Hepatology (88 citations), Reproductive Medicine (73 citations), Cognitive Neuroscience (154 citations), Cancer Research (98 citations) and Physiology (165 citations). Lanlan Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Guoyue Lv, Chang He, Yang Liu, Haitao Li, Ren‐Shan Ge, Yan Chen, Xue You, Lin Wang, Meiqin Huang and Jingyu Zhao. Their work appears in journals such as Frontiers in Pharmacology, Pharmacology, Hepatology International, Scientific Reports and Therapeutics and Clinical Risk Management.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.